EHC Operating Margin | Encompass Health Corporation

Encompass Health Corporation (EHC) Operating Margin

Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..

Operating margin

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

Metric	Value	Formula and calculation
Operating margin · 12 months	(m)	Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m).

Calculation inputs

Input	Amount with unit	Raw financial data
Operating income	(m)	Operating Income (Loss)
Revenue	6.21B USD	Revenue from Contract with Customer, Excluding Assessed Tax
Cost of products and services	(m)
Research and development	(m)
Selling, general and administration	(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period ending	Operating income (USD)	Revenue (USD)	Cost of products and services (USD)	Research and development (USD)	Selling, general and administration (USD)	Operating margin
2026-06-30	(m)	$6.21B	(m)	(m)	(m)	(m)
2026-03-31	(m)	$6.07B	(m)	(m)	(m)	(m)
2025-12-31	(m)	$5.94B	(m)	(m)	(m)	(m)
2025-09-30	(m)	$5.80B	(m)	(m)	(m)	(m)
2025-06-30	(m)	$5.67B	(m)	(m)	(m)	(m)
2025-03-31	(m)	$5.51B	(m)	(m)	(m)	(m)
2024-12-31	(m)	$5.37B	(m)	(m)	(m)	(m)
2024-09-30	(m)	$5.21B	(m)	(m)	(m)	(m)
2024-06-30	(m)	$5.07B	(m)	(m)	(m)	(m)
2024-03-31	(m)	$4.96B	(m)	(m)	(m)	(m)
2023-12-31	(m)	$4.80B	(m)	(m)	(m)	(m)
2023-09-30	(m)	$4.69B	(m)	(m)	(m)	(m)
2023-06-30	(m)	$4.57B	(m)	(m)	(m)	(m)
2023-03-31	(m)	$4.45B	(m)	(m)	(m)	(m)
2022-12-31	$539.50M	$4.35B	(m)	(m)	(m)	12.41%
2022-09-30	(m)	$5.36B	(m)	(m)	(m)	(m)
2022-06-30	(m)	$5.27B	(m)	(m)	(m)	(m)
2022-03-31	(m)	$5.22B	(m)	(m)	(m)	(m)
2021-12-31	(m)	$5.12B	(m)	(m)	(m)	(m)
2021-09-30	(m)	$5.02B	(m)	(m)	(m)	(m)
2021-06-30	(m)	$4.91B	(m)	(m)	(m)	(m)
2021-03-31	(m)	$4.69B	(m)	(m)	(m)	(m)
2020-12-31	$563.90M	$4.64B	(m)	(m)	(m)	12.14%
2020-09-30	(m)	$4.61B	(m)	(m)	(m)	(m)
2020-06-30	(m)	$4.60B	(m)	(m)	(m)	(m)
2020-03-31	(m)	$4.66B	(m)	(m)	(m)	(m)
2019-12-31	$612.10M	$4.61B	(m)	(m)	(m)	13.29%
2019-09-30	(m)	$4.52B	(m)	(m)	(m)	(m)
2019-06-30	(m)	$4.42B	(m)	(m)	(m)	(m)
2019-03-31	(m)	$4.36B	(m)	(m)	(m)	(m)
2018-12-31	$555.20M	$4.28B	(m)	(m)	(m)	12.98%
2018-09-30	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	$581.20M	$4.00B	(m)	(m)	(m)	14.52%
2017-12-31	$578.30M	(m)	(m)	(m)	(m)	(m)
2017-09-30	$579.10M	(m)	(m)	(m)	(m)	(m)
2017-06-30	$582.10M	(m)	(m)	(m)	(m)	(m)
2017-03-31	$591.00M	(m)	(m)	(m)	(m)	(m)
2016-12-31	$588.10M	(m)	(m)	(m)	(m)	(m)
2016-09-30	$578.10M	(m)	(m)	(m)	(m)	(m)
2016-06-30	$551.10M	(m)	(m)	(m)	(m)	(m)
2016-03-31	$524.30M	(m)	(m)	(m)	(m)	(m)
2015-12-31	$485.70M	(m)	(m)	(m)	(m)	(m)
2015-09-30	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	(m)	(m)	(m)	(m)	(m)	(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Pediatrix Medical Group, Inc. (MD)	United States	$2.084B	11.76